Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).

Abstract

BACKGROUND Chronic kidney disease (CKD) is an increasing public health issue. It is therefore potentially highly advantageous to identify patients at risk of accelerated renal progression and death. Neutrophil gelatinase-associated lipocalin (NGAL) is an established urinary biomarker for acute kidney injury, but it is not known whether adding urinary NGAL… (More)
DOI: 10.1093/ndt/gfs586

Topics

5 Figures and Tables

Cite this paper

@article{Smith2013UrinaryNG, title={Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).}, author={Edward R Smith and Darren Lee and Michael M X Cai and Laurie A. Tomlinson and Martin L. Ford and Lawrence P. McMahon and Stephen G. Holt}, journal={Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association}, year={2013}, volume={28 6}, pages={1569-79} }